ARTICLE | Company News
Nortran, AstraZeneca deal
October 23, 2000 7:00 AM UTC
NRT granted AZN exclusive worldwide rights to develop and market its small molecule antiarrhythmic compound. NRT will receive an upfront payment plus milestone payments and royalties, and retains righ...